Cargando…

Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9

Detalles Bibliográficos
Autores principales: Temiz, Mustafa Zafer, Cakir, Omer Onur, Kandirali, Engin, Semercioz, Atilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769264/
https://www.ncbi.nlm.nih.gov/pubmed/29345697
http://dx.doi.org/10.4103/iju.IJU_341_17
_version_ 1783292867169484800
author Temiz, Mustafa Zafer
Cakir, Omer Onur
Kandirali, Engin
Semercioz, Atilla
author_facet Temiz, Mustafa Zafer
Cakir, Omer Onur
Kandirali, Engin
Semercioz, Atilla
author_sort Temiz, Mustafa Zafer
collection PubMed
description
format Online
Article
Text
id pubmed-5769264
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57692642018-01-17 Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9 Temiz, Mustafa Zafer Cakir, Omer Onur Kandirali, Engin Semercioz, Atilla Indian J Urol Letters to Editor Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5769264/ /pubmed/29345697 http://dx.doi.org/10.4103/iju.IJU_341_17 Text en Copyright: © 2017 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Temiz, Mustafa Zafer
Cakir, Omer Onur
Kandirali, Engin
Semercioz, Atilla
Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
title Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
title_full Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
title_fullStr Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
title_full_unstemmed Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
title_short Re: Singh A et al. Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
title_sort re: singh a et al. robot-assisted retroperitoneal lymph node dissection: feasibility and outcome in postchemotherapy residual mass in testicular cancer. indian j urol 2017;33:304-9
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769264/
https://www.ncbi.nlm.nih.gov/pubmed/29345697
http://dx.doi.org/10.4103/iju.IJU_341_17
work_keys_str_mv AT temizmustafazafer resinghaetalrobotassistedretroperitoneallymphnodedissectionfeasibilityandoutcomeinpostchemotherapyresidualmassintesticularcancerindianjurol2017333049
AT cakiromeronur resinghaetalrobotassistedretroperitoneallymphnodedissectionfeasibilityandoutcomeinpostchemotherapyresidualmassintesticularcancerindianjurol2017333049
AT kandiraliengin resinghaetalrobotassistedretroperitoneallymphnodedissectionfeasibilityandoutcomeinpostchemotherapyresidualmassintesticularcancerindianjurol2017333049
AT semerciozatilla resinghaetalrobotassistedretroperitoneallymphnodedissectionfeasibilityandoutcomeinpostchemotherapyresidualmassintesticularcancerindianjurol2017333049